ArticleBMC infectious diseases2025
Perception of Rubella and readiness to accept the vaccine among medical students in Enugu and Ebonyi States, Nigeria.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRubella and Congenital Rubella Syndrome (CRS) affect children with several complications and high mortality.
objectiveThis sis to document the knowledge of rubella disease and readiness to receive Rubella vaccine among clinical medical students.
methodsThis study was carried out in three medical schools in Enugu and Abakaliki metropolis from May 2025 to June 2025. Two hundred and forty-one clinical medical students from three medical schools in Southeast Nigeria were enlisted in the study using a two-stage random sampling. The study was done with the use of interviewer-administered questionnaire.
resultsA minority of the respondents 16 (6.5%) have heard of rubella disease while a small proportion of respondents 32 (13%) knew of Rubella disease. Only 34 (13.8%) of respondents are ready to receive rubella vaccination. The proportion of respondents with good knowledge was highest among those aged 19–29 years 32(13.4%). Seventy-one (42.8%) of males indicated readiness to be vaccinated, a figure slightly higher than 32 (40.0%) of females that also showed readiness to be vaccinated. The association was not statistically significant (χ² = 0.17, p = 0.680), and the odds ratio of 1.1 (95% CI: 0.6–1.9) was noted.
conclusionA good number of clinical medical students had poor knowledge of Rubella disease. A small number of them were ready to receive the vaccine especially the female folk. This study will inform the urgent need for curriculum changes and the WHO-recommended RCV introduction in Nigeria. A multi-faceted and well organized policy for rubella vaccination especially among the female folk is prime. This will include the involvement of global health initiatives, collaboration between the state and federal government aimed to eliminate the disease through global immunization. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.